105 studies found for:    johnstown
Show Display Options
Rank Status Study
1 Completed
Has Results
Bevacizumab, Cisplatin, Radiation Therapy, and Fluorouracil in Treating Patients With Stage IIB, Stage III, Stage IVA, or Stage IVB Nasopharyngeal Cancer
Conditions: Stage II Squamous Cell Carcinoma of the Nasopharynx;   Stage III Lymphoepithelioma of the Nasopharynx;   Stage III Squamous Cell Carcinoma of the Nasopharynx;   Stage IV Lymphoepithelioma of the Nasopharynx;   Stage IV Squamous Cell Carcinoma of the Nasopharynx
Interventions: Radiation: 3-dimensional conformal radiation therapy;   Radiation: intensity-modulated radiation therapy;   Biological: bevacizumab;   Drug: cisplatin;   Drug: fluorouracil
2 Active, not recruiting Bevacizumab With or Without Trebananib in Treating Patients With Recurrent Brain Tumors
Conditions: Adult Anaplastic Oligodendroglioma;   Adult Giant Cell Glioblastoma;   Adult Glioblastoma;   Adult Gliosarcoma;   Adult Oligodendroglioma;   Recurrent Adult Brain Tumor
Interventions: Biological: bevacizumab;   Biological: trebananib;   Other: placebo;   Other: pharmacological study;   Other: laboratory biomarker analysis
3 Active, not recruiting Temozolomide and Radiation Therapy With or Without Bevacizumab in Treating Patients With Newly Diagnosed Glioblastoma
Conditions: Adult Giant Cell Glioblastoma;   Adult Glioblastoma;   Adult Gliosarcoma;   Cognitive/Functional Effects
Interventions: Drug: temozolomide;   Biological: bevacizumab;   Other: placebo;   Radiation: intensity-modulated radiation therapy;   Radiation: 3-dimensional conformal radiation therapy;   Other: quality-of-life assessment;   Other: laboratory biomarker analysis;   Procedure: dynamic susceptibility contrast-enhanced magnetic resonance imaging;   Procedure: dynamic contrast-enhanced magnetic resonance imaging
4 Active, not recruiting Higher Per Daily Treatment-Dose Radiation Therapy or Standard Per Daily Treatment Radiation Therapy in Treating Patients With Early-Stage Breast Cancer That Was Removed by Surgery
Condition: Breast Cancer
Interventions: Radiation: Whole breast irradiation delivered by 3-dimensional conformal radiation therapy or intensity modulated radiation therapy;   Radiation: Higher per daily radiation therapy;   Radiation: Concurrent boost radiotherapy;   Radiation: Standard per daily radiation therapy;   Radiation: Sequential boost radiotherapy
5 Active, not recruiting Bendamustine in Combination With Lenalidomide and Dexamethasone in Refractory or Relapsed Multiple Myeloma
Condition: Myeloma
Interventions: Drug: Bendamustine;   Drug: Lenalidomide;   Drug: Dexamethasone;   Drug: Aspirin;   Drug: Prophylaxis;   Drug: Antibiotic;   Other: Biweekly Follow Up;   Other: Cyclical Follow Up;   Other: Restaging;   Other: Post-Treatment Follow Up
6 Completed Phase II Trial of Doxorubicin and Bortezomib in Patients With Incurable Adenoid Cystic Carcinoma of the Head and Neck
Condition: Adenoid Cystic Carcinoma
Intervention: Drug: doxorubicin and bortezomib
7 Completed
Has Results
Phase II Trial of RAD001 (Everolimus) in Previously Treated Small Cell Lung Cancer
Condition: Small Cell Lung Cancer
Intervention: Drug: RAD001 (everolimus)
8 Withdrawn Trial of Radiotherapy and Panitumumab in Salivary Gland Malignancies
Conditions: Adenoma, Pleomorphic;   Mixed Salivary Gland Tumor;   Salivary Gland Tumor, Mixed;   Syringoma, Chondroid
Interventions: Radiation: Radiation;   Drug: Panitumumab
9 Completed Comparative Study Between Continuous Epidural Anesthesia And Continuous Spinal Anesthesia Using Wiley™ Spinal Catheter
Condition: Anesthesia; Adverse Effect, Spinal and Epidural
Interventions: Device: Epidural (B. Braun);   Device: Spinal (Wiley Spinal Catheter)
10 Completed Combination Chemotherapy in Treating Patients With Advanced Colorectal Cancer
Condition: Colorectal Cancer
Interventions: Drug: FOLFOX regimen;   Drug: fluorouracil;   Drug: leucovorin calcium;   Drug: oxaliplatin
11 Completed A Study To Compare Pregabalin/PF-00489791 Combination Versus Pregabalin Alone In Post-Herpetic Neuralgia
Condition: Postherpetic Neuralgia
Interventions: Drug: pregabalin;   Drug: pregabalin/PF-00489791;   Drug: Placebo
12 Unknown  An Open-Label Safety Study Of DIC075V (Intravenous Diclofenac Sodium) In Patients With Acute Post-Operative Pain
Condition: Pain, Postoperative
Intervention: Drug: DIC075V  (intravenous diclofenac sodium)
13 Completed Paclitaxel and Cisplatin Plus Radiation Therapy Followed by Filgrastim in Treating Patients With Recurrent Head and Neck Cancer or Lung Cancer
Conditions: Head and Neck Cancer;   Lung Cancer
Interventions: Biological: filgrastim;   Drug: cisplatin;   Drug: paclitaxel;   Radiation: radiation therapy
14 Completed A Study to Evaluate the Efficacy and Safety of Celecoxib Suspension Compared to Naproxen Suspension in Patients With JRA
Condition: Arthritis, Juvenile Rheumatoid
Interventions: Drug: Celecoxib;   Drug: Naproxen
15 Active, not recruiting Memantine in Preventing Side Effects in Patients Undergoing Whole-Brain Radiation Therapy for Brain Metastases From Solid Tumors
Conditions: Cognitive/Functional Effects;   Metastatic Cancer;   Neurotoxicity;   Unspecified Adult Solid Tumor, Protocol Specific
Interventions: Drug: memantine hydrochloride;   Other: placebo;   Radiation: radiation therapy
16 Completed
Has Results
A Phase III Trial For Patients With Metastatic Breast Cancer
Conditions: Breast Cancer;   Breast Neoplasms;   Cancer of the Breast
Interventions: Drug: gemcitabine;   Drug: docetaxel;   Drug: capecitabine
17 Active, not recruiting
Has Results
Persistence Study of GSK Bio's Tdap Vaccine 1, 3, 5 and 10 Years After Administration as a Single Dose in 106316 Study
Conditions: Acellular Pertussis;   Tetanus;   Diphtheria
Interventions: Procedure: Taking of blood samples;   Biological: Boostrix;   Biological: Adacel
18 Active, not recruiting Analgesic Efficacy and Management of Opioid-induced Constipation (OIC) for Uncontrolled Moderate - Severe Low Back Pain
Condition: Low Back Pain
Interventions: Drug: Oxycodone/Naloxone controlled-release;   Drug: Oxycodone HCl controlled-release;   Drug: Placebo
19 Completed
Has Results
Safety & Efficacy of Peginesatide for the Treatment of Anemia in Participants With Chronic Renal Failure Not on Dialysis
Conditions: Chronic Renal Failure;   Chronic Kidney Disease;   Anemia
Interventions: Drug: peginesatide;   Drug: Darbepoetin alfa
20 Completed Safety Study of Memantine in Pediatric Patients With Autism, Asperger's Disorder or Pervasive Developmental Disorder Not Otherwise Specified (PDD-NOS)
Conditions: Autism Spectrum Disorder (ASD);   Autism;   Autistic Disorder;   Asperger's Disorder;   Asperger's;   Pediatric Autism;   Pervasive Developmental Disorder Not Otherwise Specified (PDD-NOS);   Pervasive Child Development Disorder
Intervention: Drug: Memantine Hydrochloride (HCl)

Previous Page Studies Shown (1-20) Next Page (21-40) Show next page of results
Indicates status has not been verified in more than two years